z-logo
open-access-imgOpen Access
Eribulin for heavily pre-treated metastatic breast cancer patients
Author(s) -
Antonia Digklia
Publication year - 2015
Publication title -
world journal of experimental medicine
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2220-315X
DOI - 10.5493/wjem.v5.i3.194
Subject(s) - eribulin , medicine , metastatic breast cancer , oncology , breast cancer , adverse effect , progressive disease , cancer , chemotherapy , surgery
To discuss treatment with eribulin in clinical practice outside a clinical trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom